After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Becton Dickinson & Co is listed on the NYSE in the Healthcare sector while operating in the Medical Instruments & Supplies industry. The current market capitalization of Becton Dickinson & Co is $54.74B. A total of 3.03 million shares were traded on the day, compared to an average of 1.98M shares.
In the most recent transaction, SCOTT BERTRAM L sold 217 shares of BDX for 176.58 per share on Nov 07 ’25. After the transaction, the Director now owns 35,816 company shares. In a previous transaction on Nov 07 ’25, BERTRAM SCOTT bought 217 shares at 176.58 per share.
Among the insiders who sold shares, Feld Michael disposed of 57 shares on Oct 27 ’25 at a per-share price of $186.01. This resulted in the EVP & President, Life Sciences holding 8,245 shares of BDX after the transaction. In another insider transaction, MICHAEL FELD bought 57 shares at $185.83 per share on Oct 27 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Becton Dickinson & Co pays an annual dividend of $4.16, resulting in a dividend yield of 2.18%, and it has a price to earnings (P/E) ratio of 32.75.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BDX has a high of $251.99 and a low of $162.29.
As of this writing, BDX has an earnings estimate of $2.81 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $2.83 per share and a lower estimate of $2.79. The company reported an EPS of $3.43 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BDX’s latest balance sheet shows that the firm has $2.29B in Cash & Short Term Investments as of fiscal 2021. There were $17.61B in debt and $6.63B in liabilities at the time. Its Book Value Per Share was $88.87, while its Total Shareholder’s Equity was $23.68B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDX is Buy with a score of 3.81.
